UTHR News and Press, United Therapeutics Corporation From 02/20/24

2024-02-20 11:20:24 ET More on United Therapeutics Anticompetitive Behavior At United Therapeutics United Therapeutics: Cheap With Litigation Headwinds Liquidia jumps on win in patent case against United Therapeutics (update) The most crowded pharma longs and...

2024-02-15 11:35:43 ET Summary Liquidia Corporation shares rallied over 80% after an appeals court invalidated the patent of rival United Therapeutics, potentially paving the way for approval of its PAH and PH-ILD medication Yutrepia. However, the FDA recently extended the origina...

2024-02-14 19:49:34 ET Summary MannKind sold a 10% stake in Tyvaso DPI for $150 million upfront, with an additional $50 million possible, indicating the potential value of the remaining 9% to be upwards of $1.8 billion. Liquidia's likely entry into the market with a competing form...

United Therapeutics Corporation (Nasdaq: UTHR ), announced today that it will report its fourth quarter and full year 2023 financial results before the market opens on Wednesday, February 21, 2024. United Therapeutics will host a public webcast Wednesday, February 21, 2024, at 9:00 a.m. E...

2024-02-12 22:49:38 ET Summary Liquidia's stock has increased in value by 209.32% since June 2022. Liquidia's PAH drug, Yutrepia, is expected to launch in the first or second quarter of 2024, potentially leading to profitability. Liquidia has gained a major partnership for a s...

2024-02-12 13:00:10 ET Chris Shibutani from Goldman Sachs issued a price target of $215.00 for UTHR on 2024-02-12 11:00:00. The adjusted price target was set to $215.00. At the time of the announcement, UTHR was trading at $214.74. The overall price target consensus is a...

2024-01-25 08:32:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips From CRISPR gene editing to modify ideal agricultural traits, synthetic biology to promote eco-friendly engineering, or even that relating to biofuels, the field of biotechnology, also known as...

2024-01-25 06:48:59 ET More on Liquidia Chris DeMuth Sure Likes Uranium And SHF Holdings + 3 Litigation Ideas Liquidia Gains Edge In PAH Market Following Key Legal Victory Liquidia Corporation (LQDA) Q3 2023 Earnings Call Transcript Liquidia announces updates...

2024-01-19 08:00:00 ET Summary The healthcare sector is overvalued by 12.5% based on 11-year averages. Nevertheless, the healthcare providers industry shows a good value score. iShares U.S. Healthcare ETF is an unattractive alternative to XLV. We look at 10 healthcare stocks c...

2024-01-18 11:54:11 ET More on S&P 500 Index: The Window For A Significant Stock Market Decline Is Closing Industrial Production December 2023: No Landing = No Fed Rate Cuts Dollar Rally Pauses, But Fuel From Interest Rate Adjustment May Not Be Complete N...